Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Fulham

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Synapse (New York, N.Y.)|September 6, 2007
Ex vivo and in vivo evaluation of (2R,3R)-5-[(18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporterNicolas Giboureau, Patrick Emond, Roger R Fulton, et al.
EJNMMI Radiopharmacy and Chemistry|November 12, 2020
Cyclotron-based production of <sup>68</sup>Ga, [<sup>68</sup>Ga]GaCl<sub>3</sub>, and [<sup>68</sup>Ga]Ga-PSMA-11 from a liquid targetMelissa E Rodnick, Carina Sollert, Daniela Stark, et al.
The Lancet. Oncology|September 6, 2017
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation studyNico van Zandwijk, Nick Pavlakis, Steven C Kao, et al.
Nature Protocols|March 5, 2022
Synthesis of <sup>68</sup>Ga-radiopharmaceuticals using both generator-derived and cyclotron-produced <sup>68</sup>Ga as exemplified by [<sup>68</sup>Ga]Ga-PSMA-11 for prostate cancer PET imagingMelissa E Rodnick, Carina Sollert, Daniela Stark, et al.
Blood|January 10, 2016
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma studySally F Barrington, Amy A Kirkwood, Antonella Franceschetto, et al.
Internal Medicine Journal|October 19, 2021
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma AustraliaKatherine Creeper, Bradley Augustson, Kieran Kusel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Neuroimage. Clinical|January 5, 2021
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer diseaseAylin Dincer, Brian A Gordon, Amrita Hari-Raj, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
Modeling autosomal dominant Alzheimer's disease with machine learningPatrick H Luckett, Austin McCullough, Brian A Gordon, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Synapse (New York, N.Y.)|September 6, 2007
Ex vivo and in vivo evaluation of (2R,3R)-5-[(18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporterNicolas Giboureau, Patrick Emond, Roger R Fulton, et al.
EJNMMI Radiopharmacy and Chemistry|November 12, 2020
Cyclotron-based production of <sup>68</sup>Ga, [<sup>68</sup>Ga]GaCl<sub>3</sub>, and [<sup>68</sup>Ga]Ga-PSMA-11 from a liquid targetMelissa E Rodnick, Carina Sollert, Daniela Stark, et al.
The Lancet. Oncology|September 6, 2017
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation studyNico van Zandwijk, Nick Pavlakis, Steven C Kao, et al.
Nature Protocols|March 5, 2022
Synthesis of <sup>68</sup>Ga-radiopharmaceuticals using both generator-derived and cyclotron-produced <sup>68</sup>Ga as exemplified by [<sup>68</sup>Ga]Ga-PSMA-11 for prostate cancer PET imagingMelissa E Rodnick, Carina Sollert, Daniela Stark, et al.
Blood|January 10, 2016
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma studySally F Barrington, Amy A Kirkwood, Antonella Franceschetto, et al.
Internal Medicine Journal|October 19, 2021
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma AustraliaKatherine Creeper, Bradley Augustson, Kieran Kusel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Neuroimage. Clinical|January 5, 2021
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer diseaseAylin Dincer, Brian A Gordon, Amrita Hari-Raj, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
Modeling autosomal dominant Alzheimer's disease with machine learningPatrick H Luckett, Austin McCullough, Brian A Gordon, et al.
Pageof 6